A phase Ib/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinoma

Mingzhen Zhou, Sihui Zhu, Chen Xu, Baorui Liu, Jie Shen

Investigational New Drugs · 2023 · 30 citations · 11 references

Concepts

References

11